While the chapter requires CSTD use when administering antineoplastic HDs (if the dosage form allows) and recommends CSTD use when compounding HDs, it simply makes sense to implement CSTDs for both processes. Clearly pharmacy has embraced this more expansive approach; in fact, CSTD adoption rates for compounding significantly exceed those for administration. Looking ahead, this market segment will remain busy as more facilities look to complete CSTD implementations to achieve chapter compliance.
Enter our Sweepstakes now for your chance to win the following prizes:
Just answer the following quick question for your chance to win:
Entries are limited to one entry per person in any active sweepstakes.
Thank you for your entry.